171 related articles for article (PubMed ID: 26330379)
1. Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trial.
van Vliet E; Seinen L; Roos C; Schuit E; Scheepers H; Bloemenkamp K; Duvekot JJ; van Eyck J; Kok JH; Lotgering FK; van Baar A; van Wassenaer-Leemhuis AG; Franssen MT; Porath MM; van der Post J; Franx A; Mol B; Oudijk MA
BJOG; 2016 Jun; 123(7):1107-14. PubMed ID: 26330379
[TBL] [Abstract][Full Text] [Related]
2. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
[TBL] [Abstract][Full Text] [Related]
3. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
Roos C; Spaanderman ME; Schuit E; Bloemenkamp KW; Bolte AC; Cornette J; Duvekot JJ; van Eyck J; Franssen MT; de Groot CJ; Kok JH; Kwee A; Merién A; Nij Bijvank B; Opmeer BC; Oudijk MA; van Pampus MG; Papatsonis DN; Porath MM; Scheepers HC; Scherjon SA; Sollie KM; Vijgen SM; Willekes C; Mol BW; van der Post JA; Lotgering FK;
JAMA; 2013 Jan; 309(1):41-7. PubMed ID: 23280223
[TBL] [Abstract][Full Text] [Related]
4. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
[TBL] [Abstract][Full Text] [Related]
5. Effects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTEL III trial.
van Winden T; Klumper J; Kleinrouweler CE; Tichelaar MA; Naaktgeboren CA; Nijman TA; van Baar AL; van Wassenaer-Leemhuis AG; Roseboom TJ; Van't Hooft J; Roos C; Mol BW; Pajkrt E; Oudijk MA
BJOG; 2020 Aug; 127(9):1129-1137. PubMed ID: 32124520
[TBL] [Abstract][Full Text] [Related]
6. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
Lorthe E; Kayem G;
BMC Pregnancy Childbirth; 2021 Sep; 21(1):614. PubMed ID: 34496799
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
van Vliet EO; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KW; Scheepers HC; Jaquemyn Y; van Beek E; Duvekot HJ; Franssen MT; Bijvank BN; Kok JH; Franx A; Mol BW; Oudijk MA
BMC Pregnancy Childbirth; 2014 Mar; 14():93. PubMed ID: 24589124
[TBL] [Abstract][Full Text] [Related]
8. Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial).
Roos C; Scheepers LH; Bloemenkamp KW; Bolte A; Cornette J; Derks JB; Duvekot HJ; van Eyck J; Kok JH; Kwee A; Merién A; Opmeer BC; van Pampus MG; Papatsonis DN; Porath MM; van der Post JA; Scherjon SA; Sollie K; Spaanderman ME; Vijgen SM; Willekes C; Mol BW; Lotgering FK
BMC Pregnancy Childbirth; 2009 Sep; 9():42. PubMed ID: 19737426
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysis.
van Vliet E; Dijkema GH; Schuit E; Heida KY; Roos C; van der Post J; Parry EC; McCowan L; Lyell DJ; El-Sayed YY; Carr DB; Clark AL; Mahdy ZA; Uma M; Sayin NC; Varol GF; Mol BW; Oudijk MA
BJOG; 2016 Oct; 123(11):1753-60. PubMed ID: 27550838
[TBL] [Abstract][Full Text] [Related]
10. Impact of a randomized trial on maintenance tocolysis on length of hospital admission of women with threatened preterm labor in The Netherlands.
Lange TS; Roos C; Bloemenkamp KW; Bolte AC; Duvekot JJ; Franssen MT; Kok M; Oudijk MA; Porath MM; van der Post JA; Mol BW
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():8-11. PubMed ID: 25596476
[TBL] [Abstract][Full Text] [Related]
11. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).
Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HC; Bloemenkamp KW; Bolte AC; Cornette J; Derks JB; Duvekot JJ; van Eyck J; Kwee A; Opmeer BC; van Pampus MG; Lotgering FK; Scherjon SA; Sollie KM; Spaanderman ME; Willekes C; van der Post JA; Mol BW
BMC Pregnancy Childbirth; 2009 Sep; 9():38. PubMed ID: 19723320
[TBL] [Abstract][Full Text] [Related]
13. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour.
Naik Gaunekar N; Raman P; Bain E; Crowther CA
Cochrane Database Syst Rev; 2013 Oct; (10):CD004071. PubMed ID: 24173691
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin receptor antagonists for inhibiting preterm labour.
Flenady V; Reinebrant HE; Liley HG; Tambimuttu EG; Papatsonis DN
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004452. PubMed ID: 24903678
[TBL] [Abstract][Full Text] [Related]
15. Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study.
Klumper J; Breebaart W; Roos C; Naaktgeboren CA; van der Post J; Bosmans J; van Kaam A; Schuit E; Mol BW; Baalman J; McAuliffe F; Thornton J; Kok M; Oudijk MA
BMJ Open; 2019 Nov; 9(11):e029101. PubMed ID: 31772083
[TBL] [Abstract][Full Text] [Related]
16. Maternal admission characteristics as risk factors for preterm birth.
Papatsonis DN; van Geijn HP; Bleker OP; Ader HJ; Dekker GA
Eur J Obstet Gynecol Reprod Biol; 2004 Jan; 112(1):43-8. PubMed ID: 14687737
[TBL] [Abstract][Full Text] [Related]
17. Tocolysis compared with no tocolysis in women with threatened preterm birth and ruptured membranes: A propensity score analysis.
van Winden TMS; Roos C; Nijman TAJ; Kleinrouweler CE; Olaru A; Mol BW; McAuliffe FM; Pajkrt E; Oudijk MA
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():67-73. PubMed ID: 33096392
[TBL] [Abstract][Full Text] [Related]
18. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
19. [Tocolysis for preterm labor without premature preterm rupture of membranes].
Doret M; Kayem G
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1374-1398. PubMed ID: 28029463
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.
Coomarasamy A; Knox EM; Gee H; Song F; Khan KS
BJOG; 2003 Dec; 110(12):1045-9. PubMed ID: 14664874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
